Otolaryngology Doctors in New York, NY Accepting Medicare

270 Otolaryngology doctors found. Showing 81 - 100

Stephanie Teng, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 550 1st Ave, New York, NY 10016 Phone: 212-263-5506

Erika Ho, Otolaryngology Medicare: Medicare Enrolled Practice Location: 550 1st Ave, New York, NY 10016 Phone: 212-263-5506

Dr. Arlene H Markowitz, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 903 Park Ave, First Floor, New York, NY 10075 Phone: 212-794-3999    Fax: 212-794-3110

Dr. Ashutosh Kacker, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1305 York Ave Fl 5, New York, NY 10021 Phone: 212-746-5097    Fax: 212-746-8549

Dr. David Henry Hiltzik, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 110 E 59th St, Suite 8c, New York, NY 10022 Phone: 212-434-4500    Fax: 212-434-4580

David Culang, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 10 Union Sq E, 4j, New York, NY 10003 Phone: 212-844-8366

Courtney Brynn Tipton, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 180 Fort Washington Ave # Hp7, New York, NY 10032 Phone: 212-305-0029

David Kutler, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 160 E 34th St, 9th Fl, New York, NY 10016 Phone: 212-731-5329

Guy Lin, M.D. Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Accepting Medicare Assignments Practice Location: 150 E 58th St Fl 34, New York, NY 10155 Phone: 212-722-5570    Fax: 212-722-4573

Dr. Tom David Ben Dov, M.D. Otolaryngology - Pediatric Otolaryngology Medicare: Medicare Enrolled Practice Location: 180 Fort Washington Ave # Hp7, New York, NY 10032 Phone: 212-305-0029

Shira Leah Koss, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 310 E 14th St Fl 6, New York, NY 10003 Phone: 212-979-4223

Dr. Austin Stephen Lam, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1 Gustave L Levy Pl Fl 12, New York, NY 10029 Phone: 212-241-6500

Dr. Dean Page, Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1275 York Ave, New York, NY 10065 Phone: 021-263-9200

Dr. Dara R Liotta, M.D. Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Medicare Enrolled Practice Location: 110 E 59th St, Suite 10a, New York, NY 10022 Phone: 212-434-4500    Fax: 212-434-4508

Jonathan A Harounian, Otolaryngology Medicare: Medicare Enrolled Practice Location: 923 5th Ave Apt 1a, New York, NY 10021 Phone: 212-444-8006

Robert Anthony Guida, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1175 Park Ave, New York, NY 10128 Phone: 212-871-0900    Fax: 212-871-0909

Michelle Robin Yagoda, M.D. Otolaryngology - Facial Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5 E 83rd St, New York, NY 10028 Phone: 212-434-1210    Fax: 212-535-8155

Noel Phan, Otolaryngology Medicare: Medicare Enrolled Practice Location: 1 Gustave L Levy Pl, New York, NY 10029 Phone: 212-241-2258

Bhuvanesh Singh, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1275 York Ave, New York, NY 10021 Phone: 646-227-3813

Dr. Hyun Taik Cho, Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 170 W 12th St, Spellman 5th Floor, New York, NY 10011 Phone: 212-888-3784    Fax: 212-888-3829

News Archive

UM scientists discover high concentrations of BMAA in shark fins

Sharks are among the most threatened of marine species worldwide due to unsustainable overfishing. Sharks are primarily killed for their fins alone, to fuel the growing demand for shark fin soup, which is an Asia delicacy. A new study by University of Miami (UM) scientists in the journal Marine Drugs has discovered high concentrations of BMAA in shark fins, a neurotoxin linked to neurodegenerative diseases in humans including Alzheimer's and Lou Gehrig Disease.

Rxi Pharmaceuticals to ring Nasdaq closing bell in NYC's Times Square

RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced today that Tod Woolf, Ph.D., President and CEO, along with members of RXi's management team, will ring the Nasdaq closing bell tomorrow, Tuesday, Oct 6, 2009 at the Nasdaq Marketsite in New York City's Times Square.

Decreased removal of toxic peptides causes onset of Alzheimer's disease

Jens Pahnke and his team at the University of Oslo has recently published results in the prestigious scientific journal 'BRAIN' showing that decreased removal of toxic peptides in the brain causes the onset and first clinical signs of Alzheimer's disease, rather than overproduction as has previously been assumed. This information can now be used to target specific genes to enhance their function in the brain of elderly or people at risk.

CSHL scientist discovers how bookmarking protein triggers leukemia

Each cell inherits genes from its parent as well as epigenetic information - what amounts to an instruction manual that specifies which genes should be activated or "expressed," when and to what level.

Read more Medical News

› Verified 5 days ago

• 1
• 2
• 3
• 4
• 5(current)
• 6
• 7
• 8
• 9
• 10
• 11
• »